Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TISSEEL VH Fibrin Sealant for Lymphedema Prevention in Vulvar Cancer
NCT00028951Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Jan 2003
- Primary completion
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ARTISS in lymphedema, postoperative complications, sponsored by GOG Foundation. Started Jan 2003; status: completed.
02
Drugs
ARTISS
03
Conditions
lymphedemapostoperative complications
Beyond the preview
Go deeper on NCT00028951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028951.